1172-69 Early use of small molecule platelet glycoprotein IIb/IIIa inhibitors for all acute coronary syndrome patients is superior to selective use of abciximab for only those requiring percutaneous coronary interventions

The file will be sent to you via the Telegram messenger. It may take up to 1-5 minutes before you receive it.

Note: Make sure you have linked your account to Z-Library Telegram bot.

The file will be sent to your Kindle account. It may take up to 1–5 minutes before you receive it.

Please note: you need to verify every book you want to send to your Kindle. Check your mailbox for the verification email from Amazon Kindle.